Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03CVY
|
|||
Former ID |
DNC010246
|
|||
Drug Name |
4-(furan-3-yl)-2,6-di(thiophen-2-yl)pyridine
|
|||
Synonyms |
CHEMBL601911
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H11NOS2
|
|||
Canonical SMILES |
C1=CSC(=C1)C2=CC(=CC(=N2)C3=CC=CS3)C4=COC=C4
|
|||
InChI |
1S/C17H11NOS2/c1-3-16(20-7-1)14-9-13(12-5-6-19-11-12)10-15(18-14)17-4-2-8-21-17/h1-11H
|
|||
InChIKey |
HCNMYINNCZEXQR-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA topoisomerase II (TOP2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study. Bioorg Med Chem Lett. 2010 Jan 1;20(1):42-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.